Quarterly report [Sections 13 or 15(d)]

Statements of Operations (Unaudited)

v3.25.2
Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating expenses:        
Research and development $ 1,750 $ 4,868 $ 3,936 $ 11,681
General and administrative 5,213 2,533 11,031 4,925
Total operating expenses 6,963 7,401 14,967 16,606
Loss from operations (6,963) (7,401) (14,967) (16,606)
Other income (expenses):        
Interest income 155 462 381 532
Interest expense (13) (16) (13) (36)
Change in fair value of warrant liability 374 16,810 8,722 5,002
Total other income (expenses) 516 17,256 9,090 5,498
Net income (loss) (6,447) 9,855 (5,877) (11,108)
Dividend to Series B-1 preferred stockholders (887) (1,095)
Net income attributable to participating securities (5,925)
Net income (loss) attributable to common stockholders $ (6,447) $ 3,043 $ (5,877) $ (12,203)
Net income (loss) per share attributable to common stockholders, basic (in Dollars per share) $ (0.52) $ 0.8 $ (0.49) $ (3.35)
Net loss per share attributable to common stockholders, diluted (in Dollars per share) $ (0.52) $ (1.5) $ (0.49) $ (3.35)
Weighted-average shares outstanding used in computing net income (loss) per share, basic (in Shares) 12,302,059 3,791,481 11,993,663 3,639,800
Weighted-average shares outstanding used in computing net loss per share, diluted (in Shares) 12,302,059 9,405,285 11,993,663 3,639,800